https://www.selleckchem.com/pr....oducts/fen1-in-4.htm
after COVID-19-associated AKI. Solid estimates of the risk of developing symptoms and of progressing to critical disease in individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are key to interpreting coronavirus disease 2019 (COVID-19) dynamics, identifying the settings and the segments of the population where transmission is more likely to remain undetected, and defining effective control strategies. To estimate the association of age with the likelihood of developing symptoms and the association of
Like
Comment
Share
